Fibroblast-directed PET imaging reveals a case of retroperitoneal fibrosis after immunotherapy for metastatic urothelial cancer of the upper tract

Fibroblast-directed PET imaging reveals a case of retroperitoneal fibrosis after immunotherapy for metastatic urothelial cancer of the upper tract

Urothelial carcinomas of the upper urinary tract (UTUC) are relatively rare and challenging to treat. We present a case report of a 55-year-old male patient with high-grade renal UTUC who received adjuvant pembrolizumab immunotherapy. The patient developed retroperitoneal fibrosis as an immune-relat...

Full description

Saved in:
Bibliographic Details
Main Authors: L. Gallardo Zamora, F.C. von Rundstedt, C. Wach, W.P. Fendler, I. Maric, K. Herrmann, J.T. Siveke, P.F.-Y. Cheung, V. Grünwald
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Urology Case Reports
Subjects:
Urothelial carcinoma
Upper urinary tract
Retroperitoneal fibrosis
Immune-related adverse event
Pembrolizumab
68Ga FAPI-46 PET/CT
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442025001767
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items